MILenARI

Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region

07/05/2026 PROJECTS
MILenARI establishes the basis for future clinical trials in CAR-T therapies
SMART
MILenARI establishes the basis for future clinical trials in CAR-T therapies

The project has just launched the phase that frames the regulatory foundations for its future CAR-T clinical trials across the four Mediterranean countries involved.

Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region

29/04/2026 PROJECTS
MILenARI partners take part in training to improve internal management
SMART
MILenARI partners take part in training to improve internal management

Silvia Casas, project coordinator of the initiative led by Clínic-IDIBAPS, conducted a training session to share best practices with the other MILenARI partners and improve internal coordination and governance.

Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region

22/04/2026 OPPORTUNITIES PROJECTS
MILenARI partner, King Hussein Cancer Center, opens a vacancy for a Medical Technologist in Jordan
SMART
MILenARI partner, King Hussein Cancer Center, opens a vacancy for a Medical Technologist in Jordan

The King Hussein Cancer Center (KHCC) is seeking to hire a Medical Technologist to join its Cell Therapy & Applied Genomics Department within the Blood and Marrow Transplant Laboratory (BMT Lab).

Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region

17/04/2026 PROJECTS
American University of Beirut staff receive training for CAR-T production in Barcelona for MILenARI project
SMART
09/04/2026 PROJECTS
MILenARI project maintains momentum amid Middle East conflict
SMART
MILenARI project maintains momentum amid Middle East conflict

Despite the conflict in the Middle East and the uncertainties it brings, the MILenARI project continues to advance its mission: bringing accessible, academic CAR T cell therapy to the Mediterranean region.

Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region

09/04/2026 PROJECTS
MILenARI launches its official LinkedIn page
SMART
MILenARI launches its official LinkedIn page

The MILenARI project announce the launch of its official LinkedIn page, a new communication channel designed to share project updates, milestones, and key achievements with a wide professional audience.

Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region

26/03/2026 PROJECTS
Bambino Gesù Children’s Hospital Leads MILenARI Clinical Trial Preparation for Academic CAR‑T Across the Mediterranean
SMART
Bambino Gesù Children’s Hospital Leads MILenARI Clinical Trial Preparation

Ospedale Pediatrico Bambino Gesù (OPBG) plays a pivotal role in the MILenARI project by coordinating the preparation of future international clinical studies.

Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region

09/03/2026 PROJECTS
The American University of Beirut, MILenARI partner, will establish one of the first academic CAR-T facilities in the Middle East
SMART
The American University of Beirut, MILenARI partner, will establish one of the first academic CAR-T facilities in the Middle East

The American University of Beirut (AUB) joins MILenARI as a key partner driving the decentralisation of CAR‑T production across Mediterranean Partner Countries. AUB co‑leads the work package dedicated to the establishment, certification, and validation of CAR‑T manufacturing facilities.

Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region

02/03/2026 PROJECTS
King Hussein Cancer Center joins MILenARI to advance CAR‑T manufacturing in Jordan
SMART
King Hussein Cancer Center joins MILenARI to advance CAR‑T manufacturing in Jordan

The King Hussein Cancer Center (KHCC), the largest specialised cancer institution in the Middle East, plays a strategic role in the MILenARI consortium. With a highly active Bone Marrow Transplant Programme and newly built cell therapy facilities, KHCC is poised to become a regional hub for academic CAR‑T development.

Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region